Email This Article

Headlines & Perspectives
ImClone Soars on Erbitux Study Results
By Adam Feuerstein
09/11/07 - 10:38 AM EDT
A large phase III study shows the drug prolonging survival in lung cancer patients.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,461.60 1,110.85 2,194.20 33.79
Oil *
78.86
UP
8.92
UP
1.61
UP
9.17
UP
0.56
10 Yr
3.38%
SPDR Gold
119.42
+0.09%
+0.15%
+0.42%
+1.69%
Data delayed 20 minutes

Brokerage Partners